Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
18F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 01, 2021
Diffuse lesions secondary to sarcoidosis mimicking widespread metastatic breast cancer: A case report.
Journal: Clinical case reports
Published: June 15, 2020
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.
Journal: Cancer cell
Published: September 13, 2017
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.
Journal: Cancer cell
Published: June 13, 2016
Pulmonary langerhans cell histiocytosis: PET/CT for initial workup and treatment response evaluation.
Journal: Clinical nuclear medicine
Published: July 08, 2014
Bronchial carcinoid and primary hyperparathyroidism.
Journal: The Journal of clinical endocrinology and metabolism
Published: September 24, 2013
Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: April 12, 2012
Occult breast cancer presenting as metastatic adenocarcinoma of unknown primary: clinical presentation, immunohistochemistry, and molecular analysis.
Journal: Case reports in oncology
Published: March 02, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026